Browsing by Author "Kefeli, Umut"
Now showing items 1-11 of 11
-
Clinical importance of discordance in hormone receptor and HER2/NEU status after neoadjuvant chemotherapy in breast cancer
Öven Ustaalioğlu, Bala Başak; Aker Vardar, Fügen; Bilici, Ahmet; Gürleyik, Günay; Erkol, Burçak; Kefeli, Umut (Elsevier, 2014)Aim: Neoadjuvant chemotherapy (NAC) is used longer for both locally advanced breast cancer and early stage to increase breast conservation. Discordance of the hormone receptor (HR) status was reported to be 8-33% of the ... -
Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer
Öven Ustaalioğlu, Bala Başak; Aker Vardar, Fügen; Bilici, Ahmet; Gürleyik, Günay; Erkol, Burçak; Kefeli, Umut; Aliustaoglu, Mehmet (Zerbinis Medical Publications, 2014)Purpose: The aim of this study was to compare the hormone receptors' (HR) and HER2/neu status between core needle biopsy (CNB) and residual tumor after surgery of breast cancer treated with neoadjuvant chemotherapy (NAC), ... -
Evaluation of prognostic factors and adjuvant chemotherapy in patients with small bowel adenocarcinoma who underwent curative resection
Aydın, Dinçer; Şendur, Mehmet Ali; Kefeli, Umut; Ünal, Ölçün Ümit; Taştekin, Didem; Akyol, Murat; Tanrıkulu, Eda; Çiltaş, Aydın; Ustaalioğlu, Başak Bala; Uysal, Mükremin; Esbağ, Onur; Yazılıtaş, Doğan; Tanrıverdi, Özgür; Bilici, Ahmet; Arpacı, Erkan; Berk, Veli; Yetişyiğit, Tarkan; Özdemir, Nuriye Yıldırım; Öztop, İlhan; Alacacıoğlu, Ahmet; Aydın, Özhan; Özçelik, Melike; Yıldırım, Emre; Dinç, Nur; Gümüş, Mahmut (Cıg Media Group, LP, 2017)This is a multicenter study to assess the prognostic factors and adjuvant chemotherapy in patients with small bowel adenocarcinoma (SBA). A total of 78 patients with SBA diagnosed with completely resected SBA were involved ... -
Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of anatolian Society of medical oncology (ASMO)
Aydın, Dinçer; Şendur, Mehmet Ali; Kefeli, Umut; Ünal, Olçun Umut; Taştekin, Didem; Akyol, Murat; Tanrıkulu, Eda; Çiltaş, Aydin; Ustaalioğlu Bala, Başak; Dede Şener, Didem; Esbağ, Onur; İnal, Ali; Bilir, Cemil; Bilici, Ahmet; Harputlu, Hakan; Berk, Veli; Sevinç, Alper; Özdemir Yıldırım, Nuriye; Yıldırım, Emre; Sonkaya, Alper; Ustaoğlu, Mehmet Ali; Gümüş, Mahmut (Imprimatur Publications, 2016)Purpose: Small bowel adenocarcinoma (SBA) is a rare tumor of the gastrointestinal system with poor prognosis. Since these are rarely encountered tumors, there are limited numbers of studies investigating systemic treatment ... -
The prognostic factors for operated gallbladder cancer
Öven Ustaalioğlu, Bala Başak; Bilici, Ahmet; Şeker, Mesut; Kefeli, Umut; Dinçer, Aydın (Oxford University Press, 2017)Introduction: Surgery is the only curative treatment for localized gallbladder cancer. The prognosis is poor because low rate of patients can be found eligible for potential curative surgery. Lymph node metastasis is known ... -
Prognostic factors for operated gallbladder cancer
Öven Ustaalıoğlu, Bala Başak; Bilici, Ahmet Erkan; Şeker, Mesut Metin; Kefeli, Umut; Aydın, Dinçer; Çelik, Serkan; Demir, Tarık; Erkol, Burçak (Humana Press Inc., 2019)Purpose: The prognosis of gallbladder cancer is poor. Lymph node metastasis and the stage are known to be the strongest prognostic factors for survival. The aim of this study was to determine the importance of complementary ... -
Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy
Aydın, Dinçer; Bilici, Ahmet Erkan; Yavuzer, Dilek; Kefeli, Umut; Tan, A.; Ercelep, Özlem Balvan; Mert, Aslıhan Güven; Yüksel, Sinemis; Özçelik, Melike; Işık, Deniz; Sürmeli, Heves; Odabaşı, Hatice; Aliustaoǧlu, Mehmet (Springer-Verlag, 2015)A disintegrin and metalloproteinase (ADAM) 17 has been indicated to be an indispensable regulator of cellular events from proliferation to migration. Although prognostic importance of ADAM17 expression has been investigated ... -
Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study
Artaç, Mehmet; Çubukçu, Erdem; Bozkurt, Oktay; Bilici, Ahmet; Çelik, S.; Özçelik, M.; Öven, B.; Şimşek, E.; Geredeli, C.; Karaca, M.; Cil, T.; Harputluoğlu, Hakan; Şendur, Mehmet Ali Nahit; Türk, H. Mehmet; Kefeli, Umut; Alacacıoğlu, Ahmet; Tural, D.; Sakin, A.; Karadurmuş, Nuri; Çevik, Duygu; Dane, Faysal; Gümüş, Mahmut (Elsevier, 2022)Background: Randomized clinical trials showed that maintenance chemotherapy plus biologics in patients with mCRC could increase the progression free survival (PFS) without any advantage for overall survival (OS). Our aim ... -
Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer
Kefeli, Umut; Arslan, Çağatay; Yıldırım, Mahmut Emre; Işıkdoğan, Abdurrahman; Karadurmuş, Nuri; Karabulut, Bülent; Çubukçu, Erdem; Çiçin, İrfan; Yalçın, Şuayib; Türk, Hacı Mehmet; Bilir, Cemil; Karaca, Mustafa; Artaç, Mehmet; Şendur, Mehmet Nahit; Alacacıoğlu, Ahmet; Tanrıkulu Şimşek, Eda; Dane, Faysal; Bilici, Ahmet; Çevik, Duygu; Gümüş, Mahmut (Lippincott Williams & Wilkins, 2021)Background: Efficacy of anti-angiogenic and anti-EGFR agents has been demonstrated metastatic colorectal cancer (mCRC). Real-world evidence is especially important to detect the findings of patients outside of clinical ... -
The role of F-18-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?
Bilici, Ahmet; Öven Ustaalioğlu, Bala Başak; Şeker, Mesut; Kefeli, Umut; Canpolat, Nesrin; Tekinsoy, Bülent; Özuğur, Şule; Gümüş, Mahmut (Springer, 2011)F-18-fluorodeoxyglucose (FDG) PET/CT has been widely used for staging, re-staging and for monitoring therapy-induced changes and response to therapy in patients with various types of cancer, but its utilization for gastric ... -
Surgical, pathological and clinical features of advanced collorectal cancers with metastasectomy. "Onco-Colon Turkey Registry" real-life data
Karadurmuş, Nuri; Yıldırım, Emre; Yalçın, Şuayib; Gümüş, Mahmut; Bilir, Cemil; Çubukçu, Erdem; Tanrıkulu Şimşek, Eda; Arslan, Çağatay; Dane, Faysal; Çelik, Sinemiş; Bilici, Ahmet; Şendur, Mehmet Ali Nahit; Öven, Başak Bala; Işıkdoğan, Abdurrahman; Türk, Hacı Mehmet; Karaca, Mustafa; Karabulut, Bülent; Özçelik, Melike; Çevik, Duygu; Kefeli, Umut (Lippincott Williams & Wilkins, 2022)Background: The contribution of metastasectomy to progression-free survival (PFS) and overall survival (OS) in patients (pts) with advanced stage colorectal cancer has been demonstrated in clinical trials. However, clinical ...
